Sunstone Capital is a venture capital firm that invests in life science and technology companies with a focus on Series A and Series B funding. The firm aims to provide early-stage investments to innovative startups, particularly in the biotech and medtech sectors.

Sunstone Life Science Ventures’ is a European, early-stage investor based in Copenhagen. We invest in drug development opportunities across the European Life Science sector, and prefer to make our initial investment in companies raising Series A/B rounds based on solid in-vivo preclinical data and a well understood mechanism of action that fits well into the pathology.We seek opportunities which improve patient outcome. Our team brings together a diverse set of professional experiences: from entrepreneurial ventures to corporate management and financial services. Our background allows us to support our portfolio companies on a breadth of issues, ranging from high strategic level to specific operational issues. 

Acarix

Ascelia Pharma

Galecto

Rigontec

Santaris Pharma

Nuevolution

Dubsmash

Egalet

Forendo Pharma

IO Biotech

Orphazyme

Prexton Therapeutics

Sunstone Life Science Ventures

Sunstone Capital

EU:SUNSTONE

Sunstone Capital

Analysis Not Available